Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Gross Profit | 2,310 | 2,040 | 1,940 | 2,200 | 1,930 |
| Operating Expenses | 4,240 | 6,230 | 5,400 | 6,770 | 6,860 |
| Operating Income | -4,240 | -6,230 | -5,400 | -6,770 | -6,860 |
| Pre-tax Income | -4,240 | -6,230 | -5,400 | -6,770 | -6,860 |
| Net Income Continuous | -4,240 | -6,230 | -5,400 | -6,770 | -6,860 |
| Net Income | $-4,240 | $-6,230 | $-5,400 | $-6,770 | $-6,860 |
| EBITDA(a) | $-3,430 | $-5,110 | $-3,630 | $-6,900 | $-6,140 |